EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial

Andrew Morrow iD, Robin Young, George R Abraham iD, Stephen Hoole iD, John P Greenwood, Jayanth Ranjit Arnold iD, Mohamed El Shibly iD, Mayooran Shanmuganathan iD, Vanessa Ferreira iD, Roby Rakhit, Gavin Galasko iD, Aish Sinha iD und 19 weitere

Circulation · 19.11.2024 · 150 (21) · 1671-1683

DOI: 10.1161/circulationaha.124.069901 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 19.11.2024. Verfasst von Andrew Morrow und 30 weiteren Autor:innen. Beteiligte Einrichtung: British Heart Foundation Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, United Kingdom…. Hauptthemen laut MEDLINE: Cross-Over Studies, Microvascular Angina. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, UKRI | Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Microvascular angina is associated with dysregulation of the endothelin system and impairments in myocardial blood flow, exercise capacity, and health-related quality of life. The G allele of the noncoding single nucleotide polymorphism RS9349379 enhances expression of the endothelin-1 gene ( EDN1 ) in human vascular cells, potentially increasing circulating concentrations of Endothelin-1 (ET-1). Whether zibotentan, an oral ET-A receptor selective antagonist, is efficacious and safe for the treatment of microvascular angina is unknown. METHODS: Patients with microvascular angina were enrolled in this double-blind, placebo-controlled, sequential crossover trial of zibotentan (10 mg daily for 12 weeks). The trial population was enriched to ensure a G allele frequency of 50% for the RS9349379 single nucleotide polymorphism. Participants and investigators were blinded to genotype. The primary outcome was treadmill exercise duration (seconds) using the Bruce protocol. The primary analysis estimated the mean within-participant difference in exercise duration after treatment with zibotentan versus placebo. RESULTS: A total of 118 participants (mean±SD; years of age 63.5 [9.2]; 71 [60.2%] females; 25 [21.2%] with diabetes) were randomized. Among 103 participants with complete data, the mean exercise duration with zibotentan treatment compared with placebo was not different (between-treatment difference, −4.26 seconds [95% CI, −19.60 to 11.06] P =0.5871). Secondary outcomes showed no improvement with zibotentan. Zibotentan reduced blood pressure and increased plasma concentrations of ET-1. Adverse events were more common with zibotentan (60.2%) compared with placebo (14.4%; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross-Over StudiesMicrovascular AnginaHumansMaleFemaleMiddle AgedDouble-Blind MethodAgedEndothelin A Receptor AntagonistsTreatment OutcomePolymorphism, Single NucleotideEndothelin-1Pyrrolidines

Stichwörter der Autor:innen

angina with no obstructive coronary arteriesendothelin receptor antagonistexercise testgeneticsmicrovascular anginapharmacotherapy

Substanzen

Endothelin A Receptor AntagonistsEndothelin-1Pyrrolidines

Autor:innen und Institutionen

  • British Heart Foundation Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, United Kingdom (A.M., N.S., P.W.M., P.W., C.B.).
  • Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, United Kingdom (R.Y., A.M.).
  • Royal Papworth Hospital National Health Service (NHS) Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom (G.R.A., S.H.).
  • Baker Heart and Diabetes Institute, Melbourne, Australia (J.P.G).
  • University of Leicester and the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre, Glenfield Hospital, United Kingdom (J.R.A., M.E.S.).
  • Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, NIHR Oxford Biomedical Research Centre, University of Oxford, John Radcliffe Hospital, Unite…

ORCID-Profile: Andrew Morrow, George R Abraham, Stephen Hoole, Jayanth Ranjit Arnold, Mohamed El Shibly, Mayooran Shanmuganathan, Vanessa Ferreira, Gavin Galasko, Aish Sinha, Divaka Perera, Rasha Al-Lamee, Ioakim Spyridopoulos, Ashish Kotecha, Gerald Clesham, Thomas J Ford, Anthony Davenport, Sandosh Padmanabhan, Lisa Jolly, Peter Kellman, Juan Carlos Kaski, Robin A Weir, Naveed Sattar, Peter W Macfarlane, Paul Welsh, Alex McConnachie, Colin Berry

Förderung

  • Medical Research Council
  • UKRI | Medical Research Council

Zitieren

APA

Morrow, A., Young, R., Abraham, G. R., Hoole, S., Greenwood, J. P., Arnold, J. R., El Shibly, M., Shanmuganathan, M., Ferreira, V., Rakhit, R., Galasko, G., Sinha, A., Perera, D., Al-Lamee, R., Spyridopoulos, I., Kotecha, A., Clesham, G., Ford, T. J., Davenport, A., …, & PRIZE Study Group (2024). Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial. Circulation, 150(21), 1671-1683. https://doi.org/10.1161/circulationaha.124.069901

Vancouver

Morrow A, Young R, Abraham GR, Hoole S, Greenwood JP, Arnold JR, et al. Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial. Circulation. 2024;150(21):1671-1683. doi:10.1161/circulationaha.124.069901

BibTeX
@article{Morrow2024,
  author = {Morrow, Andrew and Young, Robin and Abraham, George R and Hoole, Stephen and Greenwood, John P and Arnold, Jayanth Ranjit and El Shibly, Mohamed and Shanmuganathan, Mayooran and Ferreira, Vanessa and Rakhit, Roby and Galasko, Gavin and Sinha, Aish and Perera, Divaka and Al-Lamee, Rasha and Spyridopoulos, Ioakim and Kotecha, Ashish and Clesham, Gerald and Ford, Thomas J and Davenport, Anthony and Padmanabhan, Sandosh and Jolly, Lisa and Kellman, Peter and Kaski, Juan Carlos and Weir, Robin A and Sattar, Naveed and Kennedy, Julie and Macfarlane, Peter W and Welsh, Paul and McConnachie, Alex and Berry, Colin and PRIZE Study Group, PRIZE Study Group},
  title = {Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial},
  journal = {Circulation},
  year = {2024},
  volume = {150},
  number = {21},
  pages = {1671--1683},
  doi = {10.1161/circulationaha.124.069901}
}
Kostenlos starten →